Protein Modeling Validation Hub

Problem Context

Researchers modeling large proteins (like CREBBP with 2,400 amino acids) need to validate mutations for neurodevelopmental disorders. They use AlphaFold3 and Dynamut2 but lack guidance on reliable parameters and binding target identification. Their lab has no bioinformatics support, forcing them to manually piece together workflows from scattered resources.

Pain Points

They struggle with unreliable simulation results due to unclear validation criteria, spend hours manually searching for binding targets, and lack tools to analyze regulatory motifs. Current workarounds (like ad-hoc parameter tweaking) waste time and risk incorrect conclusions. Without proper validation, their findings may not meet publication standards.

Impact

Wasted lab time delays research progress, grant funding risks increase from unreliable data, and career advancement stalls if publications are rejected. Poor validation could lead to incorrect therapeutic targets, costing pharma companies millions in failed drug development. The lack of standardized tools forces researchers to reinvent the wheel for each project.

Urgency

This is mission-critical for publication deadlines and grant applications. Without proper validation, their entire project could be invalidated by reviewers. The longer they work with unreliable tools, the more time and money they lose. Competitors who use validated workflows will publish first with stronger data.

Target Audience

Lone bioinformaticians in wet labs, neuroscience researchers studying developmental disorders, structural biologists modeling large proteins, and pharma researchers validating drug targets. Academic labs without dedicated bioinformatics support and small biotech teams with limited budgets also face this problem.

Solution Approach

A specialized web platform that wraps AlphaFold3 and Dynamut2 with proprietary validation rules, curated binding target databases, and regulatory motif analysis. It provides a single interface for end-to-end protein modeling workflows with built-in reliability scoring. The tool automatically checks simulations against biological plausibility and flags low-confidence results.

Key Features

1. Binding Target Predictor: Curated database of CREBBP binding partners with confidence scores and literature references.
2. Regulatory Motif Scanner: Integrates with JASPAR to identify functional motifs in wild-type vs. mutant sequences.
3. Validation Dashboard: Shows reliability metrics for each mutation, including thermodynamic stability changes and structural impact visualizations.

User Experience

Users upload their protein sequence and mutations, then select their target disorder (e.g., neurodevelopmental). The platform runs validated simulations, identifies binding targets, and scans for regulatory motifs—all in one workflow. They get a single report with reliability scores, structural visualizations, and publication-ready figures. No need to piece together tools or guess at parameters.

Differentiation

Unlike raw AlphaFold3/Dynamut2, this provides *guaranteed reliability- through proprietary validation rules. The binding target database is *curated for CREBBP- (not generic), and the motif scanner integrates directly with structural data. Competitors either lack validation guidance or require manual setup. Our 'Validation Score' becomes the industry standard for mutation analysis reliability.

Scalability

Starts with CREBBP but expands to other scaffold proteins (BRD4, EP300). Adds modules for other disorders (cancer, metabolic diseases). Enterprise version includes API access for pharma pipelines. Monthly database updates ensure users always have the latest binding targets and validation rules.

Expected Impact

Users get *publication-ready data in hours- instead of weeks. Labs reduce grant rejection risks from unreliable data. Pharma teams validate targets faster, cutting drug development costs. The platform becomes the *standard validation tool- for structural biology, cited in papers and taught in courses.